Moreover, IL‐3R is overexpressed on chronic myelogenous leukemia (CML) blasts, so Bellavia et al coated a fragment of IL‐3 on exosomes to precisely target CML cells. The gene discussed is IL3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.